Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Dallin Andersen (NPI 1225492333)

Field	Value
Entity Type	Individual
Organization	Dallin Andersen
Address	427 S Bernard St
City	Spokane
State	WA
ZIP	99204
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 6, 2016

Payer Source	Total Paid
Medicare	$3.4M
Medicaid	$0

Key Findings

This provider is essentially a Medicare-focused ophthalmology practice: lifetime Medicare revenue is $3.4M and there is no Medicaid billing on file. The absence of any Medicaid claims means the payer mix is effectively single-payer (Medicare) and the provider’s revenue base and referral channels are concentrated in the Medicare population. The NPI was enumerated 2016-04-06 (~10 years ago), indicating an established presence over roughly a decade.

Revenue concentration is heavily weighted to anti-VEGF and intravitreal drug administration: the top three Medicare codes (J0178, J2777, J2778) account for 83.9% of Medicare revenue, with J0178 at 41.0%, J2777 at 24.9%, and J2778 at 18.0%. This level of concentration indicates the practice’s financial performance is driven primarily by repeated intravitreal injections for retinal disease rather than broad E/M or routine ophthalmic outpatient services.

The code mix and specific services billed point to a retina-focused procedural practice that combines frequent drug injections with advanced retinal imaging and occasional surgery. High-volume anti-VEGF codes (J0178, J2777, J2778) are complemented by 92134 (2.3K claims, $65.9K revenue) — an OCT imaging code that is an "extreme outlier, far above typical national volume" at the 97th percentile — and procedural codes such as 67028 (1.9K claims, $190.5K revenue) that support frequent intravitreal procedures. Together these signals are consistent with a practice model organized around retinal disease management (intravitreal injections plus diagnostic imaging and episodic vitreoretinal surgery).

Competitive standing is mixed across the top drugs: J0178 (aflibercept) ranks #533 of 3204 providers nationally (83th percentile; typical, unremarkable volume for this code), J2777 (faricimab) ranks #313 of 2039 (85th percentile; typical, unremarkable volume), while J2778 (ranibizumab) ranks #92 of 1208 (92th percentile; typical, unremarkable volume). In plain terms, the provider is a high-volume participant for ranibizumab relative to national peers (near the top decile) and has solid but not dominant national positions for aflibercept and faricimab.

Procedure-level detail reinforces a high procedural throughput for retina care: 92134’s 2.3K claims and 97th-percentile designation as an "extreme outlier, far above typical national volume" indicates unusually intensive retinal imaging activity relative to peers, and 67028 shows 1.9K claims with $190.5K revenue (5.7% of Medicare revenue) and an 89th-percentile placement described as "typical, unremarkable volume for this code" yet high relative to most providers. These patterns suggest workflows optimized for repeated in-office diagnostics and injections rather than primarily clinic-based E/M encounters.

There is modest diversification within drug and device billing beyond the top three agents: J3490 (unclassified drugs) generated $95.4K (2.8% of Medicare revenue) with a 40th-percentile ranking noted as "typical, unremarkable volume for this code," and Q5124 (ranibizumab biosimilar, byooviz) contributed $26.6K (0.8% of revenue) with a 20th-percentile ranking. This indicates occasional use of unclassified or biosimilar agents but not a major revenue driver compared with the core anti-VEGF medicines.

Medicare-only exposure creates business and contracting implications: with $3.4M in Medicare revenue and no Medicaid billing on file, payer concentration risk is elevated and the provider’s negotiating leverage or patient access may be sensitive to changes in Medicare coding, reimbursement for intravitreal drugs, or utilization patterns. Given the decade-long NPI tenure (enumerated 2016-04-06 (~10 years ago)) and the concentrated anti-VEGF/imaging profile, stakeholders should treat this entity as an established, procedure-centric retina practice with limited Medicaid footprint.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,020	$690	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	28,980	$30	$840.4K
J2778	Injection, ranibizumab, 0.1 mg	3,330	$180	$605.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,910	$100	$190.5K
J3490	Unclassified drugs	50	$1,990	$95.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,270	$30	$65.9K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	200	$160	$32.1K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	170	$160	$26.6K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	30	$910	$25.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	210	$90	$19.8K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Dallin Andersen — 2 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	16	50	12,780	$30	$599.7K
J0178	16	90	470	$680	$597.2K
J2778	1	30	510	$180	$117.1K
67028	8	110	550	$90	$72.9K
J3490	38	70	70	$50	$51.2K
Q5124	4	10	220	$170	$48.7K
J7312	12	20	270	$160	$46K
67042	15	40	30	$1,190	$39.2K
67113	6	10	20	$1,240	$32.2K
92242	19	20	50	$210	$19.7K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Dallin Andersen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Spokane Eye Clinic Ps	WA	Multi-Specialty Clinic/Center	$0	$8M
Spokane Eye Clinic Ps	WA	Ambulatory Surgical Clinic/Center	$3M	$716.1K
Robert Wirthlin	WA	Ophthalmology Physician	$3.7M	$0
Andrew Cheek	WA	Ophthalmology Physician	$3.5M	$0
Loren Jack	WA	Ophthalmology Physician	$3.4M	$0
Ryan Whitted	GA	Ophthalmology Physician	$2.5M	$0
Robert Welch	UT	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Louis Chorich	OH	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Johnstone Kim	OH	Retina Specialist (Ophthalmology) Physician	$2M	$0
Shelly Lee	WA	Ophthalmology Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Dallin Andersen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Providence Health & Services - Wa	WA	General Acute Care Hospital	$0	$78.7M
Providence Health & Services Washington	WA	Pulmonary Disease Physician	$0	$78.6M
Multicare Health System	WA	General Acute Care Hospital	$0	$55.1M
New Horizon Care Center, Inc.	WA	Substance Abuse Rehabilitation Facility	$0	$20.2M
Spokane Addiction Recovery Centers	WA	Substance Abuse Rehabilitation Facility	$0	$19M
Spokane Emergency Care Physicians PLLC	WA	Emergency Medicine Physician	$0	$13.9M
Spokane Emergency Physicians, Ps	WA	Emergency Medicine Physician	$0	$13.1M
Providence Health & Services Washington	WA	Clinical Medical Laboratory	$1.6M	$9.3M
Laboratory Corporation Of America	WA	Clinical Medical Laboratory	$1.6M	$6.1M
Integra Imaging, Ps	WA	Diagnostic Radiology Physician	$0	$7.5M

Dallin Andersen — Billing Profile & Reimbursement Data

Sign up for Dallin Andersen — Billing Profile & Reimbursement Data policy alerts

Dallin Andersen — Billing Profile & Reimbursement Data

Sign up for Dallin Andersen — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References